US 6909000
Bridged bicyclic serine protease inhibitors
expired A61KA61K38/00A61P
Quick answer
US patent 6909000 (Bridged bicyclic serine protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12, A61P31/14